or Try an Advanced Search...

    Alpha 1 Antitrypsin Deficiency Stocks List

    Symbol Grade Name % Change
    ALNY D Alnylam Pharmaceuticals, Inc. 0.43
    KRRO D Korro Bio, Inc. 5.97
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Acute Intermittent Porphyria Alnylam Pharmaceuticals Alpha 1 Antitrypsin Amyloid Amyloidosis Antitrypsin Deficiency Beta Thalassemia Biotechnology Cholesterol Clinical Development Deficiency Genzyme Hemoglobin Hemoglobinopathies Hemophilia Hemophilia A Hepatology Huntington's Disease Hypercholesterolemia

    Related ETFs - A few ETFs which own one or more of the above listed Alpha 1 Antitrypsin Deficiency stocks.

    Symbol Grade Name Weight
    HRTS D Tema Cardiovascular and Metabolic ETF 4.95
    PBE D PowerShares Dynamic Biotech & Genome 4.78
    MNTL D Tema Neuroscience and Mental Health ETF 4.52
    MEDX F Horizon Kinetics Medical ETF 4.45
    FCUS A Pinnacle Focused Opportunities ETF 3.78
    View all Alpha 1 Antitrypsin Deficiency ETFs...
    Compare ETFs
    Compare HRTS to FCUS Compare HRTS to PBE Compare MNTL to MEDX

        Alpha 1 Antitrypsin Deficiency Stocks Recent News

        Date Stock Title
        Nov 21 KRRO Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency
        Nov 18 ALNY Alnylam releases encouraging interim data on nucresiran for ATTR amyloidosis
        Nov 18 ALNY ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
        Nov 18 ALNY Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
        Nov 17 ALNY Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Acute Intermittent Porphyria Alnylam Pharmaceuticals Alpha 1 Antitrypsin Amyloid Amyloidosis Antitrypsin Deficiency Beta Thalassemia Biotechnology Cholesterol Clinical Development Deficiency Genzyme Hemoglobin Hemoglobinopathies Hemophilia Hemophilia A Hepatology Huntington's Disease Hypercholesterolemia
        Alpha 1 Antitrypsin Deficiency

        Browse All Tags